NCT04928547 is a clinical trial of Test in Carotid Plaque Stability, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

Who is sponsoring NCT04928547?

NCT04928547 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

What drugs are being tested in NCT04928547?

Interventions in NCT04928547: Test.

What condition does NCT04928547 study?

NCT04928547 studies Carotid Plaque Stability.

Is NCT04928547 still recruiting?

NCT04928547 is currently status unknown. Last updated 16 June 2021.

Last reviewed 2021-06-16 · How we verify

NCT04928547

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Integrated System for the Assessment of Carotid Plaque Stability Based on the Artificial Intelligence

Status unknown Last updated 16 June 2021

What this trial tests

trial testing Test in Carotid Plaque Stability in 100 participants. Status unknown.

Timeline

15 July 2021

Primary endpoint
15 July 2021

15 July 2023

Quick facts

Lead sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	15 July 2021
Primary completion	15 July 2021
Estimated completion	15 July 2023

Drugs / interventions tested

Test — full drug profile →

Conditions studied

Carotid Plaque Stability — all drugs for Carotid Plaque Stability →

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

Adults 18 to 80, any sex, with Carotid Plaque Stability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The project will be properly embedded in the clinical practice landscape to both provide a real-world context for research requirements gathering and research result assessment, and a practical application context from the industrial perspective. The landing is planned for cardiology solutions as carotid plaque assessment that can be value-adding features to tackle the current challenges of stroke prediction. The development of stroke prediction model could accelerate the R\&D process and land to key market ultrasound prototypes/products in an agile way. Collaboration and alignment with key market business and R\&D (China Digital Innovation CDI) through workshops and hackathons will be a unique feature of this agile project.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Test

Trials testing the same drug.

NCT06003465 — A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices · Phase 1 · completed
NCT05867862 — Implementation of a Program to Strengthen Oral Hygiene in Patient With Cleft Deformities · NA · completed
NCT06010355 — Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities · NA · terminated
NCT05085587 — Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharm · Phase 1 · unknown
NCT05194826 — Using Fascia Lata Membrane Versus Connective Tissue Graft in Immediate Implants · NA · unknown

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04928547 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
Last refreshed: 16 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04928547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing